I think that's optimistic.
Let's say they start Jan/Feb 2016. I can't imagine they'd be able to crunch through even a small, quick trial in less than six months, in fact I'd say 6 months is impossibly optimistic, more like 9 months to a year. Then they've got to go through the FDA process and it seems to take 6 months to make anything happen there. If they get to Ph III in 2016 I'd be impressed. Given we know the trials will be sequential, I really can't see Ph III starting in 1H 2016. I would be very happy to be wrong.
Timelines., page-24
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.66 |
Change
-0.090(0.65%) |
Mkt cap ! $1.753B | |||
| Open | High | Low | Value | Volume |
| $13.85 | $14.08 | $13.46 | $4.414M | 322.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 589 | $13.66 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.67 | 282 | 14 |
View Market Depth
| Last trade - 15.01pm 10/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |